NDAORALTABLETPriority Review
Approved
Oct 1958
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 10h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DIABINESE (chlorpropamide) is an oral first-generation sulfonylurea approved in 1958 for type 2 diabetes management. It works by stimulating pancreatic beta cells to increase insulin secretion, lowering blood glucose in patients with non-insulin-dependent diabetes. This is a legacy small-molecule therapeutic from Pfizer's foundational diabetes portfolio.
LOE Approaching
This legacy product faces significant competitive pressure (30/100) and declining market relevance, suggesting minimal team growth and likely defensive commercial positioning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
DIABINESE offers minimal career advancement potential given its LOE status, zero linked job postings, and declining market relevance. Working on this product typically involves defensive commercial strategies, generic price management, or specialized supply roles rather than growth-oriented career development.
Generic Product ManagerSupply Chain Specialist
Worked on DIABINESE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.